UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) October 10, 2018

                           UNITED CANNABIS CORPORATION
                    ----------------------------------------
               (Exact name of registrant as specified in charter)

                                    Colorado
                -------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)

                            1600 Broadway, Suite 1600
      000-54582                Denver, CO 80202                 46-5221947
----------------------    ------------------------------  ---------------------
(Commission File Number)  (Address of Principal Executive   (IRS Employer
                             Offices and Zip Code)        Identification Number)


                                 (303) 386-7321
               -------------------------------------------------
              (Registrant's telephone number, including area code)


                                       N/A
             -----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)


Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:


[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
     CFR 240.14a-12(b))

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company [ ]

If an emerging  growth  company,  indicate by check mark if the  registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. [ ]

                                       1
<PAGE>

ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On October 10, 2018 the Company issued a press release, attached as Exhibit
99, providing guidance on third quarter operating results.



ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

  Number    Description

   99       October 10, 2018 Press Release









                                       2
<PAGE>


                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                       UNITED CANNABIS CORPORATION


Dated:  October 24, 2018               By:  Chad Ruby
                                            -------------------------------
                                            Chad Ruby
                                            Chief Operating Officer













                                       3


<PAGE>


                                   EXHIBIT 99

<PAGE>



       UNITED CANNABIS CORPORATION GIVES GUIDANCE ON THIRD QUARTER RESULTS

         Company To Report $2 Million In Revenue For The Third Quarter,
                      Forecasting $10 Million For the Year


Denver, CO October 10, 2018 - United Cannabis Corporation (OTCQB: CNAB) (the
"Company" or "United Cannabis") today provided preliminary, unaudited figures on
revenues for the third quarter 2018 and offered guidance for the year.

Revenues for the third quarter 2018 are $2 million,  and approximately  $4.2 for
the year to date.

Although consistent with the second quarter,  the results were somewhat impacted
by a  seasonal  shortage  of raw  materials.  The  current  harvest  season  has
alleviated the seasonal shortage and, thus,  Management  believes the Company is
still on track to report a minimum of $10 million in revenue for 2018.

The third  quarter  2018  revenues  amount has not be  subjected to an unaudited
review  by the  Company's  auditors,  and may be  subject  to  change  upon  the
completions of such unaudited review

About United Cannabis Corporation

United Cannabis Corporation is dedicated to the development of phyto-therapeutic
based  products  supported  by  patented  technologies  for the  pharmaceutical,
medical,  and industrial markets. The Company has long advocated the application
of  cannabinoids  for  medical  applications  and is  building  a  platform  for
designing targeted therapies to increase the quality of life for patients around
the world. The Company's products are patent protected, first in class medicines
with applications to a global market.  United Cannabis trades on the OTCQB under
the symbol CNAB.

For further information, please visit www.unitedcannabis.us.

<PAGE>

Contact: Staff@UnitedCannabis.us
Phone: 303-386-7321


Certain statements in this news release may contain forward-looking  information
within the meaning of Rule 175 under the  Securities Act of 1933, are subject to
Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe
harbors created by those rules.  All statements,  other than statements of fact,
included in this release,  including,  without limitation,  statements regarding
potential  future  plans and  objectives  of the  company,  are  forward-looking
statements that involve risks and uncertainties.  There can be no assurance that
such  statements  will prove to be accurate and other results and further events
could differ materially from those anticipated in such statements. Future events
and actual results could differ materially from those set forth in, contemplated
by, or underlying the forward-looking statements.
[{"type": "8-K", "sequence": "1", "filename": "form8k2023rdqrtr10-18.txt", "description": "8-K 3RD QUARTER RESULTS", "secsgml_size_bytes": 6185}]
{"company-data": {"conformed-name": "United Cannabis Corp", "cik": "0001436161", "assigned-sic": "2834", "irs-number": "261391338", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54582", "film-number": "181136078"}, "business-address": {"street1": "301 COMMERCIAL RD.", "street2": "UNIT D", "city": "GOLDEN", "state": "CO", "zip": "80401", "phone": "844-278-2420"}, "mail-address": {"street1": "301 COMMERCIAL RD.", "street2": "UNIT D", "city": "GOLDEN", "state": "CO", "zip": "80401"}, "former-company": {"former-conformed-name": "MySkin, Inc.", "date-changed": "20080528"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report: (Date of earliest event reported) October 10, 2018

                           UNITED CANNABIS CORPORATION
                    ----------------------------------------
               (Exact name of registrant as specified in charter)

                                    Colorado
                -------------------------------------------------
         (State or other Jurisdiction of Incorporation or Organization)

                            1600 Broadway, Suite 1600
      000-54582                Denver, CO 80202                 46-5221947
----------------------    ------------------------------  ---------------------
(Commission File Number)  (Address of Principal Executive   (IRS Employer
                             Offices and Zip Code)        Identification Number)

                                 (303) 386-7321
               -------------------------------------------------
              (Registrant's telephone number, including area code)

                                       N/A
             -----------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing  obligation  of  registrant  under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17
     CFR 240.14a-12(b))

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company [ ]

If an emerging  growth  company,  indicate by check mark if the  registrant  has
elected not to use the extended  transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. [ ]

                                       1
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On October 10, 2018 the Company issued a press release, attached as Exhibit
99, providing guidance on third quarter operating results.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

  Number    Description

   99       October 10, 2018 Press Release

                                       2
SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                       UNITED CANNABIS CORPORATION

Dated:  October 24, 2018               By:  Chad Ruby
                                            -------------------------------
                                            Chad Ruby
                                            Chief Operating Officer

                                       3
EXHIBIT 99
UNITED CANNABIS CORPORATION GIVES GUIDANCE ON THIRD QUARTER RESULTS

         Company To Report $2 Million In Revenue For The Third Quarter,
                      Forecasting $10 Million For the Year

Denver, CO October 10, 2018 - United Cannabis Corporation (OTCQB: CNAB) (the
"Company" or "United Cannabis") today provided preliminary, unaudited figures on
revenues for the third quarter 2018 and offered guidance for the year.

Revenues for the third quarter 2018 are $2 million,  and approximately  $4.2 for
the year to date.

Although consistent with the second quarter,  the results were somewhat impacted
by a  seasonal  shortage  of raw  materials.  The  current  harvest  season  has
alleviated the seasonal shortage and, thus,  Management  believes the Company is
still on track to report a minimum of $10 million in revenue for 2018.

The third  quarter  2018  revenues  amount has not be  subjected to an unaudited
review  by the  Company's  auditors,  and may be  subject  to  change  upon  the
completions of such unaudited review

About United Cannabis Corporation

United Cannabis Corporation is dedicated to the development of phyto-therapeutic
based  products  supported  by  patented  technologies  for the  pharmaceutical,
medical,  and industrial markets. The Company has long advocated the application
of  cannabinoids  for  medical  applications  and is  building  a  platform  for
designing targeted therapies to increase the quality of life for patients around
the world. The Company's products are patent protected, first in class medicines
with applications to a global market.  United Cannabis trades on the OTCQB under
the symbol CNAB.

For further information, please visit www.unitedcannabis.us.
Contact: Staff@UnitedCannabis.us
Phone: 303-386-7321

Certain statements in this news release may contain forward-looking  information
within the meaning of Rule 175 under the  Securities Act of 1933, are subject to
Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe
harbors created by those rules.  All statements,  other than statements of fact,
included in this release,  including,  without limitation,  statements regarding
potential  future  plans and  objectives  of the  company,  are  forward-looking
statements that involve risks and uncertainties.  There can be no assurance that
such  statements  will prove to be accurate and other results and further events
could differ materially from those anticipated in such statements. Future events
and actual results could differ materially from those set forth in, contemplated
by, or underlying the forward-looking statements.